BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+4.15%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$7.83B
AUM Growth
+$7.83B
(-4.1%)
Cap. Flow
-$147M
Cap. Flow
% of AUM
-1.88%
Top 10 Holdings %
Top 10 Hldgs %
76.05%
Holding
116
New
10
Increased
21
Reduced
11
Closed
7
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$33.4M |
| 2 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$28.8M |
| 3 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$23.4M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$18.2M |
| 5 |
XNPT
XENOPORT, INC.
XNPT
|
$15M |
Top Sells
| 1 |
ITMN
INTERMUNE INC
ITMN
|
$209M |
| 2 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$46.2M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$32.8M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$19.5M |
| 5 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$13.3M |
Sector Composition
| 1 | Healthcare | 39.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCYC
1
DELISTED
PHARMACYCLICS INC
PCYC
| $1.13B | 14.28% | 9,656,599 +65,053 | +0.7% | +$7.64M |
|
|
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
| $836M | 10.52% | 22,475,729 +3,500 | +0% | +$130K |
|
|
GEVA
3
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $733M | 9.23% | 10,660,432 | – | – |
|
4
Incyte
INCY
$16.5B
| $728M | 9.17% | 14,845,559 | – | – |
|
5
Acadia Pharmaceuticals
ACAD
$4.38B
| $507M | 6.39% | 20,481,442 | – | – |
|
|
GHDX
6
DELISTED
Genomic Health, Inc.
GHDX
| $387M | 4.87% | 13,655,618 +716 | +0% | +$20.3K |
|
|
AVNR
7
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $250M | 3.15% | 20,974,677 +2,416,190 | +13% | +$28.8M |
|
|
8
BioMarin Pharmaceuticals
BMRN
$11.2B
| $171M | 2.15% | 2,370,464 +462,234 | +24% | +$33.4M |
|
9
BioCryst Pharmaceuticals
BCRX
$1.74B
| $105M | 1.32% | 10,713,686 -177,186 | -2% | -$1.73M |
|
|
ANAC
10
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $103M | 1.3% | 4,204,702 +956,659 | +29% | +$23.4M |
|
11
Xoma
XOMA
$392M
| $97.1M | 1.22% | 23,071,472 +5,500 | +0% | +$23.2K |
|
|
DYAX
12
DELISTED
DYAX CORPORATION
DYAX
| $62.3M | 0.78% | 6,157,789 +476,552 | +8% | +$4.82M |
|
13
Cerus
CERS
$251M
| $47.9M | 0.6% | 11,940,178 +1,693,587 | +17% | +$6.79M |
|
14
Vanda Pharmaceuticals
VNDA
$279M
| $45.4M | 0.57% | 4,372,153 | – | – |
|
|
MRTX
15
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $41.7M | 0.52% | 2,380,074 | – | – |
|
|
XNPT
16
DELISTED
XENOPORT, INC.
XNPT
| $36.7M | 0.46% | 6,815,777 +2,781,665 | +69% | +$15M |
|
|
DSCI
17
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $29.5M | 0.37% | 3,537,137 | – | – |
|
|
RPRX
18
DELISTED
Repros Therapeutics Inc.
RPRX
| $27.5M | 0.35% | 2,778,654 | – | – |
|
19
Gilead Sciences
GILD
$140B
| $27.3M | 0.34% | 256,108 | – | – |
|
|
ACOR
20
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $25.5M | 0.32% | 753,391 -152,700 | -17% | -$5.17M |
|
21
Halozyme
HALO
$8.56B
| $25.3M | 0.32% | 2,776,143 | – | – |
|
|
ARAV
22
DELISTED
Aravive, Inc. Common Stock
ARAV
| $23.7M | 0.3% | 1,246,089 +200 | +0% | +$3.8K |
|
|
PGNX
23
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $23.1M | 0.29% | 4,449,797 | – | – |
|
24
Catalyst Pharmaceutical
CPRX
$2.52B
| $22.3M | 0.28% | 6,715,462 +4,492,409 | +202% | +$14.9M |
|
25
TG Therapeutics
TGTX
$4.65B
| $21.9M | 0.28% | 2,050,313 -110,652 | -5% | -$1.18M |
|